th steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin counters and sinks. Healthcare furniture products include laminate casework, systems, and related products for healthcare applications. Technical furniture products include column systems, slotted-post systems, pedestal systems, and stand-alone benches.
The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets. One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.
Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.Consolidated Statements of Operations
(in thousands, except per share data)Three Months Ended
Years EndedApril 30
April 302012
2011
2012
2011(Unaudited)Net sales$28,990
$26,952
$102,847
$100,003Cost of products sold21,638
22,247
83,691
80,719Gross profit7,352
4,705
19,156
19,284Operating expenses4,493
4,174
16,443
16,127Operating earnings2,859
531
2,713
3,157Other income (expense)43
4
271
'/>"/>SOURCE Kewaunee Scientific Corporation Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine technology :1.
Accelrys Fast-tracks Scientific Innovation with Modeling and Simulation Software Release2.
Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions3.
Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine4.
Boston Scientific Closes Cameron Health Acquisition5.
Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting6.
IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board7.
Scripps Research Institutes Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research8.
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators9.
Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology10.
Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting11.
Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona